LL'S MAGNETIC CLAY INC Recall: The recalled dietary supplement has the potential to contain undeclared allergens, including almonds, shellfish, milk, eggs, and peanuts. - F-1675-2018

🇺🇸 United States

1. June 29, 2018 - Recall initiated
2. August 8, 2018 - Reported by source
3. February 8, 2019 - Recall terminated

Official source record

Agency

FDA

Dataset

FDA Food Enforcement (Recalls)

Recall number

F-1675-2018

Event ID

80419

Status

Terminated

Classification

Class I

Company

LL'S MAGNETIC CLAY INC

Product description

Prescript-Assist Broad Spectrum Probiotic & Prebiotic Gastrointestinal Support Dietary Supplement, 60-capsule or 90-capsule bottles; UPC Codes: 853956003157, 853956003539

Quantity

290,000 units

Reason

The recalled dietary supplement has the potential to contain undeclared allergens, including almonds, shellfish, milk, eggs, and peanuts.

Recall initiation date

June 29, 2018

Report date

August 8, 2018

Classification date

Not published in this source record

Termination date

February 8, 2019

Distribution pattern

Nationwide throughout the United States and United Kingdom, Mexico, Netherlands, Sweden, Australia, Canada, Hong Kong, Spain, New Zealand, Chile, Taiwan, Switzerland, Albania, Poland, Israel, Monaco, Japan, India, Hungary, Saudi Arabia, Malaysia, UAE, Norway, France, Russia, Australia, Colombia, Czech Republic, Nigeria, Ireland, Philippines

UPC, lot, and code information

All Lots within expiry; Lot # s: 1356300 (exp. 01/2019), 1405700 (exp. 03/2019), 17A128 (exp. 03/2021), W00103 (exp. 06/2019), 16A071, 17A130, 16C076, 15D081, W00095, 15K016, W0135, 15D007, 15D080, 16B174, 16A078, 16D065, 16B041, W0176, 15D115, 16A214.

Voluntary or mandated

Voluntary: Firm initiated

Initial notification method

Press Release

Source last updated

Not tracked separately from the Public Health Trace retrieval date below

Public Health Trace retrieval date

July 18, 2026 ET

Responsible company: LL'S MAGNETIC CLAY INC

Where this information comes from

View FDA enforcement record -- the specific openFDA record this summary was built from.

This record comes from FDA's Enforcement Report database. Not every Enforcement Report record has a separate FDA.gov recall-announcement page.

FDA Enforcement Reports -- FDA's general, official recall and enforcement information. See FDA Enforcement Reports versus recall announcements for how that database differs from a press-release-style announcement.

New to reading a recall record? See how to read an FDA recall record and what recall statuses mean.

Technical source data

View raw source data -- the machine-readable record this page's information was built from.

Retrieved by Public Health Trace: July 18, 2026 ET

Frequently asked questions

What does a Class I mean?

FDA classifies this recall as Class I. See how to read an FDA recall record (linked above) for what each classification level means.

Is this recall still active?

According to FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.

What should I do if I have this product?

Follow the responsible agency's published instructions, linked below -- recall guidance is set by that agency, not by Public Health Trace.

Official guidance and record verification

Public Health Trace does not provide medical advice -- review the linked official source below for current, authoritative information.

How to interpret this historical record

This record is preserved as published by FDA, as of February 8, 2019.

Status as reported: Terminated.

This page does not imply a current danger or a current consumer instruction -- review the official source for the most current information.

View the official FDA source

This summary is based on the official source record referenced above. Public Health Trace does not state that any company or product is unsafe beyond what the official source has published. Read the full medical disclaimer.

• Email
• X / Twitter
• Facebook